| Apr 15, 2022 | — | Medical Care for Adults With Down Syndrome: Guidelines From the Global Down Syndrome Foundation [Practice Guidelines] |
| Oct 15, 2017 | — | Fetal Alcohol Syndrome and Fetal Alcohol Spectrum Disorders |
| Jun 15, 2015 | — | Role of the Family Physician in the Management of Cystic Fibrosis [Editorials] |
| Dec 15, 2014 | — | Role of the Family Physician in the Care of Children with Down Syndrome |
| Jan 01, 2014 | — | Noonan Syndrome |
| Nov 01, 2012 | — | When to Suspect a Genetic Syndrome |
| Aug 01, 2007 | — | Turner Syndrome: Diagnosis and Management |
| Dec 01, 2005 | — | Klinefelter Syndrome |
| Sep 01, 2005 | — | Prader-Willi Syndrome |
| Nov 15, 2021 | — | Should Allele Testing Be Done Before Prescribing Allopurinol to Prevent Severe Cutaneous Adverse Reactions? [FPIN's Clinical Inquiries] |
| Jul 15, 2021 | — | Pharmacogenetic Gene-Drug Associations: FDA Perspective on What Physicians Need to Know [Editorials] |
| Jul 15, 2021 | — | GeneSight Psychotropic Genetic Testing for Psychiatric Medication Selection [Diagnostic Tests] |
| Nov 01, 2019 | — | Allopurinol Hypersensitivity Assay HLA-B*58:01 Genotyping [Diagnostic Tests] |
| Oct 01, 2015 | — | Pharmacogenetics: Using Genetic Information to Guide Drug Therapy |
| Jun 01, 2008 | — | Genetic Factors in Drug Metabolism |
| Aug 01, 2007 | — | The Effect of Cytochrome P450 Metabolism on Drug Response, Interactions, and Adverse Effects |
| Apr 15, 2020 | — | Fetal Aneuploidy: Screening and Diagnostic Testing |
| Jan 01, 2019 | — | Inborn Errors of Metabolism: From Preconception to Adulthood |
| May 01, 2018 | — | Clinical and Personal Utility of Genetic Risk Testing [Curbside Consultation] |
| Jan 15, 2015 | — | Screening for Hereditary Cancer Syndromes [Curbside Consultation] |
| Jan 15, 2009 | — | Fetal Chromosomal Abnormalities: Antenatal Screening and Diagnosis |
| Feb 01, 2006 | — | At-Home Genetic Tests [Curbside Consultation] |
| Aug 01, 2005 | — | Genomic Medicine for Underserved Minority Populations in Family Medicine [Editorials] |
| Dec 15, 2009 | — | ACOG Guidelines for Managing Hereditary Breast and Ovarian Cancer Syndrome [Practice Guidelines] |
| Feb 15, 2008 | — | Cancer Genetic Risk Assessment for Individuals at Risk of Familial Breast Cancer [Cochrane for Clinicians] |
| Jun 01, 2007 | — | Screening for Hemochromatosis: Recommendation Statement [U.S. Preventive Services Task Force] |
| Nov 15, 2024 | — | Navigating Polygenic Risk Scores in Primary Care: Challenges and Considerations for Diverse Populations [Editorials] |
| Oct 01, 2015 | — | Pharmacogenetic Testing—An Unfulfilled Promise [Editorials] |
| Apr 15, 2010 | — | Family History and Genetic Testing for Cancer Risk [Letters to the Editor] |
| Dec 01, 2009 | — | The CDC's EGAPP Initiative: Evaluating the Clinical Evidence for Genetic Tests [Editorials] |
| Aug 01, 2007 | — | Is Genetic Testing for Cytochrome P450 Polymorphisms Ready for Implementation? [Editorials] |
| Dec 15, 2005 | — | Integrating Genetic Counseling into Family Medicine [Editorials] |
| Jul 01, 2005 | — | Genetic Testing: When to Test, When to Refer [Editorials] |
| Dec 15, 2014 | — | Caring for Your Baby with Down Syndrome [Information from Your Family Doctor] |
| Jan 15, 2009 | — | Prenatal Genetic Screening Tests [Information from Your Family Doctor] |
| Aug 01, 2005 | — | Family History: The Three-Generation Pedigree |